The role of host immunity in the control of HIV Infection: From theory to diagnostic and therapeutic intervention

A. Lazzarin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Different immune and virological responses to antiretroviral therapy were generally observed in a consistent part of treated patients. The immune reconstitution due to viral decay conseguent to antiretroviral therapy is principally divided in two phases (redistribution and repopulation). Several co-factors (in particular co-receptor and cytokine relationship with HIV infection) can interfere with the response to the antiviral drugs. The re-establishment of HIV target cells immune activation and the recduction of CD4 cell loss and turn-over must be considered.

Original languageEnglish
Pages (from-to)135-139
Number of pages5
JournalNew Microbiologica
Volume27
Issue number2 SUPPL. 1
Publication statusPublished - 2004

Fingerprint

HIV Infections
Immunity
Cytokine Receptors
Antiviral Agents
HIV
Therapeutics

Keywords

  • CD4 receptor
  • Cytokines
  • HIV therapy
  • Immunomodulation

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

The role of host immunity in the control of HIV Infection : From theory to diagnostic and therapeutic intervention. / Lazzarin, A.

In: New Microbiologica, Vol. 27, No. 2 SUPPL. 1, 2004, p. 135-139.

Research output: Contribution to journalArticle

@article{1574a9f7115a49c5b775223931fdb613,
title = "The role of host immunity in the control of HIV Infection: From theory to diagnostic and therapeutic intervention",
abstract = "Different immune and virological responses to antiretroviral therapy were generally observed in a consistent part of treated patients. The immune reconstitution due to viral decay conseguent to antiretroviral therapy is principally divided in two phases (redistribution and repopulation). Several co-factors (in particular co-receptor and cytokine relationship with HIV infection) can interfere with the response to the antiviral drugs. The re-establishment of HIV target cells immune activation and the recduction of CD4 cell loss and turn-over must be considered.",
keywords = "CD4 receptor, Cytokines, HIV therapy, Immunomodulation",
author = "A. Lazzarin",
year = "2004",
language = "English",
volume = "27",
pages = "135--139",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "2 SUPPL. 1",

}

TY - JOUR

T1 - The role of host immunity in the control of HIV Infection

T2 - From theory to diagnostic and therapeutic intervention

AU - Lazzarin, A.

PY - 2004

Y1 - 2004

N2 - Different immune and virological responses to antiretroviral therapy were generally observed in a consistent part of treated patients. The immune reconstitution due to viral decay conseguent to antiretroviral therapy is principally divided in two phases (redistribution and repopulation). Several co-factors (in particular co-receptor and cytokine relationship with HIV infection) can interfere with the response to the antiviral drugs. The re-establishment of HIV target cells immune activation and the recduction of CD4 cell loss and turn-over must be considered.

AB - Different immune and virological responses to antiretroviral therapy were generally observed in a consistent part of treated patients. The immune reconstitution due to viral decay conseguent to antiretroviral therapy is principally divided in two phases (redistribution and repopulation). Several co-factors (in particular co-receptor and cytokine relationship with HIV infection) can interfere with the response to the antiviral drugs. The re-establishment of HIV target cells immune activation and the recduction of CD4 cell loss and turn-over must be considered.

KW - CD4 receptor

KW - Cytokines

KW - HIV therapy

KW - Immunomodulation

UR - http://www.scopus.com/inward/record.url?scp=11844258218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11844258218&partnerID=8YFLogxK

M3 - Article

C2 - 15646077

AN - SCOPUS:11844258218

VL - 27

SP - 135

EP - 139

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 2 SUPPL. 1

ER -